40 Healthcare Stocks Moving In Thursday's After-Market Session

Gainers

• Aphria, Inc. APHA shares moved upwards by 32.0% to $6.88 during Thursday's after-market session. The market cap stands at $1.3 B. According to the most recent rating by CIBC, on 2019-07-26, the current rating is at Underperformer.
• Tandem Diabetes Care, Inc. TNDM shares increased by 9.8% to $66.11. The market cap stands at $3.4 B. According to the most recent rating by SVB Leerink, on 2019-05-13, the current rating is at Outperform, with a price target of $83.00.
• OpGen, Inc. OPGN stock increased by 7.0% to $0.34. The market cap stands at $5.5 M.
• Zynerba Pharmaceuticals, Inc. ZYNE shares surged 6.8% to $10.94. The market cap stands at $215.8 M.
• Endo International, Inc. ENDP shares rose 6.2% to $3.24. The market cap stands at $689.8 M. According to the most recent rating by Morgan Stanley, on 2019-07-15, the current rating is at Underweight, with a price target of $3.00.
• Insmed, Inc. INSM shares rose 6.1% to $20.42. The market cap stands at $1.7 B.
• Jaguar Health, Inc. JAGX shares rose 5.6% to $1.70. The market cap stands at $8.9 M.
• Coherus BioSciences, Inc. CHRS stock surged 5.3% to $17.94. The market cap stands at $1.1 B. According to the most recent rating by Barclays, on 2019-06-11, the current rating is at Overweight, with a price target of $30.00.
• OrganiGram Holdings, Inc. OGI stock surged 5.3% to $5.95. The market cap stands at $881.6 M.
• Geron, Inc. GERN shares rose 5.2% to $1.21. The market cap stands at $214.4 M.
• Trevena, Inc. TRVN stock rose 5.0% to $0.97. The market cap stands at $84.9 M. According to the most recent rating by H.C. Wainwright, on 2019-05-31, the current rating is at Buy, with a price target of $3.50.
• VBI Vaccines, Inc. VBIV stock increased by 5.0% to $0.73. The market cap stands at $67.5 M.
• Cara Therapeutics, Inc. CARA shares surged 4.6% to $23.94. The market cap stands at $1.0 B. According to the most recent rating by Piper Jaffray, on 2019-07-30, the current rating is at Overweight, with a price target of $39.00.
• Puma Biotechnology, Inc. PBYI stock increased by 4.6% to $9.85. The market cap stands at $363.7 M. According to the most recent rating by Cantor Fitzgerald, on 2019-05-10, the current rating is at Neutral, with a price target of $20.00.
• Adaptimmune Therapeutics, Inc. ADAP stock rose 4.5% to $3.08. The market cap stands at $308.9 M. According to the most recent rating by Roth Capital, on 2019-05-31, the current rating is at Buy, with a price target of $7.00.
• Acasti Pharma, Inc. ACST stock rose 4.4% to $2.59. The market cap stands at $196.4 M. According to the most recent rating by Oppenheimer, on 2019-07-18, the current rating is at Outperform, with a price target of $7.00.
• CareDx, Inc. CDNA stock moved upwards by 4.4% to $35.50. The market cap stands at $1.4 B. According to the most recent rating by H.C. Wainwright, on 2019-05-09, the current rating is at Buy, with a price target of $43.00.
• Athersys, Inc. ATHX shares surged 4.3% to $1.45. The market cap stands at $208.1 M.
• Kindred Biosciences, Inc. KIN stock increased by 4.2% to $7.25. The market cap stands at $271.4 M. According to the most recent rating by B. Riley, on 2019-07-16, the current rating is at Neutral, with a price target of $8.50.
• Salarius Pharmaceuticals, Inc. SLRX stock rose 4.2% to $5.50. The market cap stands at $19.7 M.
• Cronos Group, Inc. CRON shares rose 4.1% to $13.25. The market cap stands at $4.2 B. According to the most recent rating by Consumer Edge, on 2019-06-28, the current rating is at Equal-Weight.
• T2 Biosystems, Inc. TTOO shares surged 3.8% to $0.60. The market cap stands at $25.7 M. According to the most recent rating by Alliance Global Partners, on 2019-08-01, the current rating is at Neutral, with a price target of $0.40.
• Aurora Cannabis, Inc. ACB stock moved upwards by 3.8% to $6.07. The market cap stands at $5.9 B. According to the most recent rating by Bank of America, on 2019-07-18, the current rating is at Neutral.
• Kala Pharmaceuticals, Inc. KALA shares rose 3.7% to $6.17. The market cap stands at $201.6 M.
• Benitec Biopharma, Inc. BNTC shares rose 3.7% to $0.85. The market cap stands at $10.3 M.

Losers

• Correvio Pharma, Inc. CORV shares decreased by 13.5% to $1.60 during Thursday's after-market session. The market cap stands at $73.7 M.
• Agile Therapeutics, Inc. AGRX stock declined 11.8% to $0.97. The market cap stands at $48.1 M. According to the most recent rating by Oppenheimer, on 2019-06-07, the current rating is at Outperform, with a price target of $5.00.
• Fluidigm, Inc. FLDM shares plummeted 11.0% to $10.81. The market cap stands at $838.5 M.
• CannTrust Holdings, Inc. CTST shares plummeted 11.0% to $1.94. The market cap stands at $307.0 M. According to the most recent rating by Roth Capital, on 2019-07-09, the current rating is at Neutral.
• Iovance Biotherapeutics, Inc. IOVA stock decreased by 7.1% to $23.39. The market cap stands at $3.1 B.
• Zafgen, Inc. ZFGN shares declined 5.8% to $0.97. The market cap stands at $38.4 M.
• ENDRA Life Sciences, Inc. NDRA stock declined 4.9% to $1.35. The market cap stands at $10.5 M. According to the most recent rating by H.C. Wainwright, on 2019-07-15, the current rating is at Buy, with a price target of $6.00.
• Ocular Therapeutix, Inc. OCUL stock decreased by 4.1% to $4.70. The market cap stands at $209.9 M. According to the most recent rating by Cowen & Co., on 2019-05-21, the current rating is at Market Perform.
• Axsome Therapeutics, Inc. AXSM stock declined 3.5% to $25.04. The market cap stands at $863.9 M.
• Editas Medicine, Inc. EDIT stock fell 3.0% to $25.00. The market cap stands at $1.2 B.
• Obalon Therapeutics, Inc. OBLN shares declined 2.9% to $4.71. The market cap stands at $17.2 M.
• SINTX Technologies, Inc. SINT stock decreased by 2.8% to $2.45. The market cap stands at $1.8 M.
• Avrobio, Inc. AVRO shares fell 2.2% to $20.00. The market cap stands at $493.8 M. According to the most recent rating by Mizuho, on 2019-06-27, the current rating is at Buy, with a price target of $28.00.
• Sarepta Therapeutics, Inc. SRPT shares declined 2.0% to $145.00. The market cap stands at $10.9 B. According to the most recent rating by Morgan Stanley, on 2019-07-09, the current rating is at Overweight, with a price target of $220.00.
• Biomarin Pharmaceutical, Inc. BMRN stock decreased by 2.0% to $79.35. The market cap stands at $14.5 B.